Showing results (51-60 of 185) with videos related to

Sort By:
Pageof 19
Journal of Experimental & Clinical Cancer Research : CR|May 10, 2017
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patientsRenata A Tassi, Paola Todeschini, Eric R Siegel, et al.
Patient Preference and Adherence|September 24, 2015
Interventional tools to improve medication adherence: review of literatureElísio Costa, Anna Giardini, Magda Savin, et al.
American Journal of Obstetrics and Gynecology|May 12, 2009
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomasChiara Romani, Fabrizio Comper, Elisabetta Bandiera, et al.
European Journal of Internal Medicine|March 24, 2015
Time to face the challenge of multimorbidity. A European perspective from the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS)Graziano Onder, Katie Palmer, Rokas Navickas, et al.
Gynecologic Oncology|October 8, 2003
Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapyStefania Bellone, Michela Palmieri, Murat Gokden, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|March 1, 2019
Role of HPV DNA, HPV mRNA and cytology in the follow-up of women treated for cervical dysplasiaGiancarlo Tisi, Franco Gargiulo, Elisa Gozzini, et al.
ISRN Obstetrics and Gynecology|July 14, 2012
Prognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancerElisabetta Bandiera, Roberta Franceschini, Claudia Specchia, et al.
Cancers|July 27, 2024
Sexual Function in Women Diagnosed with Hereditary Breast and Ovarian Cancer SyndromeFederico Ferrari, Juri Amonti, Andrea Giannini, et al.
Frontiers in Oncology|November 2, 2020
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma PatientsEliana Bignotti, Laura Zanotti, Paola Todeschini, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 30, 2026
Decoding BRCA1 and BRCA2 Mutations in High-Grade Serous Ovarian Cancer: Impact of Location and Type of Mutation on Prognosis and PARP Inhibitor TreatmentMarina Momi, Elisa Salviato, Antonella Ravaggi, et al.
Pageof 19